AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,449 | +172.3% | 224,078 | +118.6% | 0.00% | – |
| Q2 2023 | $93,814 | -13.4% | 102,528 | -47.0% | 0.00% | – |
| Q1 2023 | $108,337 | +40.4% | 193,459 | +44.6% | 0.00% | – |
| Q4 2022 | $77,182 | -14.2% | 133,764 | -52.5% | 0.00% | – |
| Q3 2022 | $90,000 | -45.1% | 281,706 | -39.4% | 0.00% | – |
| Q2 2022 | $164,000 | -43.4% | 465,088 | +15.0% | 0.00% | – |
| Q1 2022 | $290,000 | -72.0% | 404,253 | -11.9% | 0.00% | – |
| Q4 2021 | $1,037,000 | +127.4% | 459,079 | +189.8% | 0.00% | – |
| Q3 2021 | $456,000 | +39.0% | 158,410 | +83.0% | 0.00% | – |
| Q2 2021 | $328,000 | -63.5% | 86,547 | -67.4% | 0.00% | – |
| Q1 2021 | $898,000 | +331.7% | 265,207 | +258.0% | 0.00% | – |
| Q4 2020 | $208,000 | -24.4% | 74,082 | -32.4% | 0.00% | – |
| Q3 2020 | $275,000 | -86.3% | 109,656 | -25.6% | 0.00% | – |
| Q2 2020 | $2,002,000 | +28.5% | 147,427 | -28.2% | 0.00% | – |
| Q1 2020 | $1,558,000 | +61.6% | 205,344 | +34.7% | 0.00% | – |
| Q4 2019 | $964,000 | +32.6% | 152,444 | -17.7% | 0.00% | – |
| Q3 2019 | $727,000 | -59.2% | 185,263 | -49.7% | 0.00% | – |
| Q2 2019 | $1,783,000 | -23.0% | 368,379 | +30.2% | 0.00% | – |
| Q1 2019 | $2,317,000 | +199.0% | 282,866 | +101.9% | 0.00% | – |
| Q4 2018 | $775,000 | -38.6% | 140,114 | -2.0% | 0.00% | – |
| Q3 2018 | $1,262,000 | -60.1% | 142,937 | -54.8% | 0.00% | -100.0% |
| Q2 2018 | $3,159,000 | +27.1% | 316,549 | +21.4% | 0.00% | – |
| Q1 2018 | $2,485,000 | -13.2% | 260,759 | +35.4% | 0.00% | – |
| Q4 2017 | $2,864,000 | -53.0% | 192,592 | -37.8% | 0.00% | -100.0% |
| Q3 2017 | $6,088,000 | +44.2% | 309,530 | +5.3% | 0.00% | 0.0% |
| Q2 2017 | $4,222,000 | +14.4% | 293,858 | -26.7% | 0.00% | 0.0% |
| Q1 2017 | $3,692,000 | -27.3% | 401,158 | -17.7% | 0.00% | 0.0% |
| Q4 2016 | $5,075,000 | +10.9% | 487,549 | -3.6% | 0.00% | 0.0% |
| Q3 2016 | $4,577,000 | -18.4% | 505,774 | -32.5% | 0.00% | 0.0% |
| Q2 2016 | $5,607,000 | -42.9% | 749,663 | -31.3% | 0.00% | -50.0% |
| Q1 2016 | $9,828,000 | +12.4% | 1,090,881 | +61.1% | 0.00% | 0.0% |
| Q4 2015 | $8,747,000 | +175.5% | 677,001 | +106.0% | 0.00% | +100.0% |
| Q3 2015 | $3,175,000 | +204.4% | 328,671 | +224.3% | 0.00% | – |
| Q2 2015 | $1,043,000 | +394.3% | 101,353 | +432.9% | 0.00% | – |
| Q1 2015 | $211,000 | -21.3% | 19,019 | -17.4% | 0.00% | – |
| Q4 2014 | $268,000 | +665.7% | 23,029 | +1356.6% | 0.00% | – |
| Q3 2014 | $35,000 | – | 1,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |